Abstract:Recently, molecular generation models based on deep learning have attracted significant attention in drug discovery. However, most existing molecular generation models have serious limitations in the context of drug design wherein they do not sufficiently consider the effect of the three-dimensional (3D) structure of the target protein in the generation process. In this study, we developed a new deep learning-based molecular generator, SBMolGen, that integrates a recurrent neural network, a Monte Carlo tree search, and docking simulations. The results of an evaluation using four target proteins (two kinases and two G protein-coupled receptors) showed that the generated molecules had a better binding affinity score (docking score) than the known active compounds, and the generated molecules possessed a broader chemical space distribution. SBMolGen not only generates novel binding active molecules but also presents 3D docking poses with target proteins, which will be useful in subsequent drug design. The code is available at <a class="extLink" href="https://github.com/clinfo/SBMolGen">https://github.com/clinfo/SBMolGen</a>.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00679?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00679</a>.Number of generated molecules, example of generated molecules for target EGFR at C = 1.0, example of generated molecules for target AA2AR at C = 1.0, example of generated molecules for target ADRB2 at C = 1.0; distribution of the similarity score of the generated molecules and distribution of the scaffold similarity score of the generated molecules; distribution of the SA scores of the generated molecules; distributions of the QED scores of the generated molecules; plots of IFIE<sub>sum</sub> against experimentally determined Δ<i>G</i> for (A) nine CDK2 inhibitors and (B) generated molecules; distribution of the docking scores of the generated molecules against DDR1; chemical structures of nine CDK2 inhibitors and their properties (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00679/suppl_file/ci1c00679_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Geom-SAC: Geometric Multi-Discrete Soft Actor Critic With Applications in De Novo Drug Design

Geometric Deep Learning for Structure-Based Ligand Design

Structure-based drug design with geometric deep learning

Learning on topological surface and geometric structure for 3D molecular generation

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

Geometric Deep Learning for Drug Discovery

De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

Advances in Deep Learning-Based 3D Molecular Generative Models

Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B

Geometric deep learning methods and applications in 3D structure-based drug design

Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning

3D-SMGE: a pipeline for scaffold-based molecular generation and evaluation

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning

De Novo Structure-Based Drug Design Using Deep Learning

Scalable Fragment-Based 3D Molecular Design with Reinforcement Learning

FragGen: Towards 3D Geometry Reliable Fragment-based Molecular Generation

Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning

DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space